Trial Profile
A Multicentre, Randomized, Assessor-blind, Comparator-Controlled, Parallel-Group Clinical Trial to Establish the Efficacy and Safety of Duac (1% Clindamycin as Clindamycin Phosphate and 5% Benzoyl Peroxide) Once Daily Gel Compared With Clindamycin Phosphate Gel (1% Clindamycin as Clindamycin Phosphate) Twice Daily in the Treatment of Mild to Moderate Acne Vulgaris.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Benzoyl peroxide/clindamycin (Primary) ; Clindamycin
- Indications Acne vulgaris
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 19 Aug 2014 New trial record